Tumor Biology

, Volume 36, Issue 6, pp 4575–4582 | Cite as

Associations of polymorphisms in microRNAs with female breast cancer risk in Chinese population

  • Bangshun He
  • Yuqin Pan
  • Yeqiong Xu
  • Qiwen Deng
  • Huling Sun
  • Tianyi Gao
  • Shukui Wang
Research Article

Abstract

Polymorphisms in microRNA (miRNA) have been discussed to be associated with breast cancer risk; however, the conclusions were always inconsistent in different ethnicities. This case–control study enrolled 450 breast cancer cases, and 450 health controls was carried out to investigate the association between six polymorphisms in miRNAs and breast cancer risk. Sequenom MassARRAY was used to detect the polymorphisms in miRNAs, and the immunohistochemistry assay was applied to detect the expression of estrogen receptor (ER) and progesterone receptor (PR) in cancer tissue. The data showed that the 3746444 GG was associated with increased breast cancer risk (adjusted odds ratio (OR) = 1.71, 95 % confidence interval (CI) = 1.16–2.52) and that rs2292832 CC (adjusted OR = 0.54, 95 % CI = 0.34–0.85) was associated with decreased breast cancer risk. In addition, menopausal status subgroup analysis revealed that rs3746444 GG (adjusted OR = 2.34, 95 % CI = 1.31–4.15) and GA/GG (adjusted OR = 1.60, 95 % CI = 1.08–2.37) genotypes were associated with increased breast cancer risk for the subgroup of women with premenopausal status, respectively. Moreover, rs2910164 GG (adjusted OR = 1.84, 95 % CI = 1.07–3.15) and CG/GG (adjusted OR = 1.47, 95 % CI = 1.01–2.15) genotypes were associated with increased breast cancer risk in the postmenopausal status subcohort, respectively. Furthermore, rs3746444 AG (adjusted OR = 1.61, 95 % CI = 1.06–2.45) and AG/GG (adjusted OR = 1.49, 95 % CI = 1.02–2.18) genotypes were observed to be associated with increased risk of lymph node involvement and breast cancer with negative PR expression, separately. In short, rs3746444 was associated with breast cancer risk, especially for women with premenopausal status, and rs2910164 CG and CG/GG genotypes were associated with breast cancer risk for the women with premenopausal status.

Keywords

Breast cancer Polymorphism MicroRNA 

Notes

Acknowledgments

This study was supported by grants from the National Nature Science Foundation of China (no. 81200401) and Nanjing Medical Science and Technique Development Foundation to BS. H (nos. JQX13003, QRX11254, QYK11175) and YQ. P (no. QRX11255).

Conflicts of interest

None

Supplementary material

13277_2015_3102_MOESM1_ESM.docx (31 kb)
Supplementary table (DOCX 31 kb)

References

  1. 1.
    Benz CC. Impact of aging on the biology of breast cancer. Crit Rev Oncol Hematol. 2008;66:65–74.CrossRefPubMedGoogle Scholar
  2. 2.
    Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small rnas with antisense complementarity to lin-14. Cell. 1993;75:843–54.CrossRefPubMedGoogle Scholar
  3. 3.
    Bartel DP. Micrornas: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97.CrossRefPubMedGoogle Scholar
  4. 4.
    Esquela-Kerscher A, Slack FJ. Oncomirs—micrornas with a role in cancer. Nat Rev Cancer. 2006;6:259–69.CrossRefPubMedGoogle Scholar
  5. 5.
    Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, et al. The role of microrna-1 and microrna-133 in skeletal muscle proliferation and differentiation. Nat Genet. 2006;38:228–33.CrossRefPubMedGoogle Scholar
  6. 6.
    Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM. Bantam encodes a developmentally regulated microrna that controls cell proliferation and regulates the proapoptotic gene hid in drosophila. Cell. 2003;113:25–36.CrossRefPubMedGoogle Scholar
  7. 7.
    Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, et al. Mir-15 and mir-16 induce apoptosis by targeting bcl2. Proc Natl Acad Sci U S A. 2005;102:13944–9.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Hatfield SD, Shcherbata HR, Fischer KA, Nakahara K, Carthew RW, Ruohola-Baker H. Stem cell division is regulated by the microrna pathway. Nature. 2005;435:974–8.CrossRefPubMedGoogle Scholar
  9. 9.
    Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al. Human microrna genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004;101:2999–3004.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, et al. Reduced expression of the let-7 micrornas in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004;64:3753–6.CrossRefPubMedGoogle Scholar
  11. 11.
    Iwai N, Naraba H. Polymorphisms in human pre-mirnas. Biochem Biophys Res Commun. 2005;331:1439–44.CrossRefPubMedGoogle Scholar
  12. 12.
    Ryan BM, Robles AI, Harris CC. Genetic variation in microrna networks: the implications for cancer research. Nat Rev Cancer. 2010;10:389–402.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    He B, Pan Y, Cho WC, Xu Y, Gu L, Nie Z, et al. The association between four genetic variants in micrornas (rs11614913, rs2910164, rs3746444, rs2292832) and cancer risk: evidence from published studies. PLoS One. 2012;7:e49032.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Catucci I, Yang R, Verderio P, Pizzamiglio S, Heesen L, Hemminki K, et al. Evaluation of snps in mir-146a, mir196a2 and mir-499 as low-penetrance alleles in german and italian familial breast cancer cases. Hum Mutat. 2010;31:E1052–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Jedlinski DJ, Gabrovska PN, Weinstein SR, Smith RA, Griffiths LR. Single nucleotide polymorphism in hsa-mir-196a-2 and breast cancer risk: a case control study. Twin Res Hum Genet. 2011;14:417–21.CrossRefPubMedGoogle Scholar
  16. 16.
    Hu Z, Liang J, Wang Z, Tian T, Zhou X, Chen J, et al. Common genetic variants in pre-micrornas were associated with increased risk of breast cancer in chinese women. Hum Mutat. 2009;30:79–84.CrossRefPubMedGoogle Scholar
  17. 17.
    Hoffman AE, Zheng T, Yi C, Leaderer D, Weidhaas J, Slack F, et al. Microrna mir-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res. 2009;69:5970–7.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Zhang M, Jin M, Yu Y, Zhang S, Wu Y, Liu H, et al. Associations of mirna polymorphisms and female physiological characteristics with breast cancer risk in chinese population. Eur J Cancer Care (Engl). 2012;21:274–80.CrossRefGoogle Scholar
  19. 19.
    Gabriel S, Ziaugra L, Tabbaa D. Snp genotyping using the sequenom massarray iplex platform. Curr Protoc Hum Genet 2009;Chapter 2:Unit 2 12.Google Scholar
  20. 20.
    Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM, et al. High-throughput oncogene mutation profiling in human cancer. Nat Genet. 2007;39:347–51.CrossRefPubMedGoogle Scholar
  21. 21.
    Gul AE, Keser SH, Barisik NO, Kandemir NO, Cakir C, Sensu S, et al. The relationship of cerb b 2 expression with estrogen receptor and progesterone receptor and prognostic parameters in endometrial carcinomas. Diagn Pathol. 2010;5:13.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Ma XP, Zhang T, Peng B, Yu L, de Jiang K. Association between microrna polymorphisms and cancer risk based on the findings of 66 case-control studies. PLoS One. 2013;8:e79584.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Srivastava K, Srivastava A. Comprehensive review of genetic association studies and meta-analyses on mirna polymorphisms and cancer risk. PLoS One. 2012;7:e50966.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Chen QH, Wang QB, Zhang B. Ethnicity modifies the association between functional microrna polymorphisms and breast cancer risk: a huge meta-analysis. Tumour Biol. 2014;35:529–43.CrossRefPubMedGoogle Scholar
  25. 25.
    Xu Y, Gu L, Pan Y, Li R, Gao T, Song G, et al. Different effects of three polymorphisms in micrornas on cancer risk in asian population: evidence from published literatures. PLoS One. 2013;8:e65123.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Ma F, Zhang P, Lin D, Yu D, Yuan P, Wang J, et al. There is no association between microrna gene polymorphisms and risk of triple negative breast cancer in a chinese han population. PLoS One. 2013;8:e60195.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Alshatwi AA, Shafi G, Hasan TN, Syed NA, Al-Hazzani AA, Alsaif MA, et al. Differential expression profile and genetic variants of micrornas sequences in breast cancer patients. PLoS One. 2012;7:e30049.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Omrani M, Hashemi M, Eskandari-Nasab E, Hasani SS, Mashhadi MA, Arbabi F, et al. Hsa-mir-499 rs3746444 gene polymorphism is associated with susceptibility to breast cancer in an iranian population. Biomark Med. 2014;8:259–67.CrossRefPubMedGoogle Scholar
  29. 29.
    Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, et al. A mammalian microrna expression atlas based on small rna library sequencing. Cell. 2007;129:1401–14.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Wang AX, Xu B, Tong N, Chen SQ, Yang Y, Zhang XW, et al. Meta-analysis confirms that a common g/c variant in the pre-mir-146a gene contributes to cancer susceptibility and that ethnicity, gender and smoking status are risk factors. Genet Mol Res. 2012;11:3051–62.CrossRefPubMedGoogle Scholar
  31. 31.
    Xu T, Zhu Y, Wei QK, Yuan Y, Zhou F, Ge YY, et al. A functional polymorphism in the mir-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis. 2008;29:2126–31.CrossRefPubMedGoogle Scholar
  32. 32.
    Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A. Common snp in pre-mir-146a decreases mature mir expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A. 2008;105:7269–74.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Bhaumik D, Scott GK, Schokrpur S, Patil CK, Campisi J, Benz CC. Expression of microrna-146 suppresses nf-kappab activity with reduction of metastatic potential in breast cancer cells. Oncogene. 2008;27:5643–7.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  • Bangshun He
    • 1
  • Yuqin Pan
    • 1
  • Yeqiong Xu
    • 2
  • Qiwen Deng
    • 1
  • Huling Sun
    • 3
  • Tianyi Gao
    • 1
  • Shukui Wang
    • 1
  1. 1.Central Laboratory, Nanjing First HospitalNanjing Medical UniversityNanjingChina
  2. 2.Changshu Medical Examination InstituteChangshuChina
  3. 3.Department of Life SciencesNanjing Normal UniversityNanjingChina

Personalised recommendations